|Articles|January 17, 2017
Chinese CROs to Adopt OmniComm TrialOne Solution
OmniComm Systems announces the signing of contracts to provide the company’s TrialOne clinical automation solution to three clinical research organizations in China.
Advertisement
OmniComm Systems announces the signing of contracts to provide the company’s TrialOne clinical automation solution to three clinical research organizations in China. The agreements for TrialOne were made with Xiyuan Hospital, the Chinese Anti-Cancer Association (CACA) and eStart Medical Technology Co., Ltd.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
2
Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First
3
AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective
4
Why Time Savings Is the Largest Driver of RBQM's Financial Value
5